»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
°³¿ä
÷´Ü X¼± °¡½ÃÈ ½Ã½ºÅÛ ½ÃÀåÀº 2023-20281³â¿¡ 4¾ï 3,448¸¸ ´Þ·¯, ¿¹Ãø ±â°£ Áß CAGRÀº 5.56%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
÷´Ü X¼± °¡½ÃÈ ½Ã½ºÅÛ ½ÃÀåÀÇ ÀüüÀûÀÎ ºÐ¼®, ½ÃÀå ±Ô¸ð¡¤¿¹Ãø, µ¿Çâ, ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦, ¾à 25°³ º¥´õ¸¦ ´Ù·é º¥´õ ºÐ¼® µîÀ» Á¦°øÇÕ´Ï´Ù.
ÇöÀçÀÇ ½ÃÀå ½Ã³ª¸®¿À, Ãֽе¿Çâ°ú ÃËÁø¿äÀÎ, ½ÃÀå ȯ°æ Àüü¿¡ °üÇÑ ÃֽŠºÐ¼®À» Á¦°øÇϰí ÀÖ½À´Ï´Ù. ½ÃÀåÀº ÇÏÀ̺긮µå ¿µ»ó ¸ð´Þ¸®Æ¼ÀÇ Á¸Àç, ±â¼ú Áøº¸¿¡ ´ëÇÑ ÁÖ¸ñÀÇ Áõ°¡, ¼±Áø±¹¿¡¼ »óȯ Á¦µµÀÇ Á¸Àç¿¡ ÀÇÇØ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù.
½ÃÀå ¹üÀ§
±âÁسâ
2024
Á¾·á³â
2028
¿¹Ãø ±â°£
2024-2028
¼ºÀå ¸ð¸àÅÒ
°¡¼Ó
Àü³â´ëºñ 2024³â
5.42%
CAGR
5.56%
ÁõºÐ¾×
4¾ï 3,448¸¸ ´Þ·¯
º» Á¶»ç¿¡¼´Â ÇâÈÄ ¼ö³â°£ ÷´Ü X¼± °¡½ÃÈ ½Ã½ºÅÛ ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎÀÇ Çϳª·Î ¼ö¼úÁß ½Ã¼ú¿ë ¼ÒÇÁÆ®¿þ¾î¸¦ žÀçÇÑ ·Îº¿ Ç÷§ÆûÀÇ Ã¤ÅÃÀ» µé°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ Å¬¶ó¿ìµå ÄÄÇ»ÆÃ¿¡ ´ëÇÑ ÁÖ¸ñÀÇ Áõ°¡ ¹× ¿Â¶óÀÎ À¯Åë ä³ÎÀÇ Àαâ Áõ°¡µµ ½ÃÀåÀÇ Å« ¼ö¿ä·Î ¿¬°áµÉ °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù.
¸ñÂ÷
Á¦1Àå ÁÖ¿ä ¿ä¾à
Á¦2Àå ½ÃÀå ±¸µµ
Á¦3Àå ½ÃÀå ±Ô¸ð
½ÃÀåÀÇ Á¤ÀÇ
½ÃÀå ºÎ¹® ºÐ¼®
½ÃÀå ±Ô¸ð 2023
½ÃÀå Àü¸Á 2023-2028
Á¦4Àå ½ÃÀå ±Ô¸ð ½ÇÀû
¼¼°èÀÇ Ã·´Ü X¼± °¡½ÃÈ ½Ã½ºÅÛ ½ÃÀå 2018-2022
Á¦Ç° ºÎ¹® ºÐ¼® 2018-2022
ÃÖÁ¾»ç¿ëÀÚ ºÎ¹® ºÐ¼® 2018-2022
Áö¿ªº° ºÎ¹® ºÐ¼® 2018-2022
±¹°¡º° ºÎ¹® ºÐ¼® 2018-2022
Á¦5Àå Five forces ºÐ¼®
Five Forces ¿ä¾à
±¸¸ÅÀÚÀÇ ±³¼··Â
°ø±Þ ±â¾÷ÀÇ ±³¼··Â
½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
´ëüǰÀÇ À§Çù
°æÀïÀÇ À§Çù
½ÃÀå ÇöȲ
Á¦6Àå ½ÃÀå ¼¼ºÐÈ : Á¦Ç°º°
½ÃÀå ºÎ¹®
ºñ±³ : Á¦Ç°º°
÷´Ü X¼± °¡½ÃÈ ½Ã½ºÅÛ 2D/3D : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028
÷´Ü X¼± °¡½ÃÈ ½Ã½ºÅÛ 3D/4D : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028
½ÃÀå ±âȸ : Á¦Ç°º°
Á¦7Àå ½ÃÀå ¼¼ºÐÈ : ÃÖÁ¾»ç¿ëÀÚº°
½ÃÀå ºÎ¹®
ºñ±³ : ÃÖÁ¾»ç¿ëÀÚº°
½ÉÀ庴ÇÐ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028
Á¾¾çÇÐ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028
Ä¡¿±³Á¤ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028
Á¤Çü¿Ü°ú ¹× ½Å°æ ³»°ú : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028
½ÃÀå ±âȸ : ÃÖÁ¾»ç¿ëÀÚº°
Á¦8Àå °í°´ »óȲ
Á¦9Àå Áö¿ªº° »óȲ
Áö¿ªº° ¼¼ºÐÈ
Áö¿ªº° ºñ±³
ºÏ¹Ì : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028
À¯·´ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028
¾Æ½Ã¾Æ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028
¼¼°èÀÇ ±âŸ Áö¿ª : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028
¹Ì±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028
µ¶ÀÏ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028
¿µ±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028
ÀϺ» : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028
ij³ª´Ù : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028
½ÃÀå ±âȸ : Áö¿ª »óȲº°
Á¦10Àå ÃËÁø¿äÀÎ, °úÁ¦ ¹× µ¿Çâ
½ÃÀå ÃËÁø¿äÀÎ
½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
ÃËÁø¿äÀΰú °úÁ¦ÀÇ ¿µÇâ
½ÃÀå µ¿Çâ
Á¦11Àå º¥´õ ±¸µµ
°³¿ä
º¥´õ ±¸µµ
È¥¶õÀÇ »óȲ
¾÷°èÀÇ ¸®½ºÅ©
Á¦12Àå º¥´õ ºÐ¼®
´ë»ó º¥´õ
º¥´õÀÇ ½ÃÀå Æ÷Áö¼Å´×
Agfa Gevaert NV
Canon Medical Systems Corp.
Carestream Health Inc.
Cefla SC
Dentsply Sirona Inc.
FUJIFILM Corp.
General Electric Co.
Hologic Inc.
Koninklijke Philips N.V.
PerkinElmer Inc
Planmeca Oy
Siemens Healthineers AG
Terarecon Inc
Thermo Fisher Scientific Inc.
Toshiba Corp.
Á¦13Àå ºÎ·Ï
KSA
Abstract
The advanced x-ray visualization systems market is forecasted to grow by USD 434.48 mn during 2023-2028, accelerating at a CAGR of 5.56% during the forecast period. The report on the advanced X-ray visualization systems market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the presence of hybrid imaging modalities, increased focus on technological advances, and the existence of reimbursements in developed countries.
Market Scope
Base Year 2024
End Year 2028
Series Year 2024-2028
Growth Momentum Accelerate
YOY 2024 5.42%
CAGR 5.56%
Incremental Value $434.48mn
Technavio's advanced x-ray visualization systems market is segmented as below:
By Product
Advanced X-ray visualization systems 2D/3D
Advanced X-ray visualization systems 3D/4D
By End-user
Cardiology
Oncology
Orthodontics
Orthopedic and neurology
By Geographical Landscape
North America
Europe
Asia
Rest of World (ROW)
This study identifies the adoption of robotic platforms with software for intraoperative procedures as one of the prime reasons driving the advanced x-ray visualization systems market growth during the next few years. Also, increased focus on cloud computing and the increasing popularity of online distribution channels will lead to sizable demand in the market.
The report on the advanced x-ray visualization systems market covers the following areas:
Advanced x-ray visualization systems market sizing
Advanced x-ray visualization systems market forecast
Advanced x-ray visualization systems market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading advanced x-ray visualization systems market vendors that include Agfa Gevaert NV, Align Technology Inc., Canon Medical Systems Corp., Carestream Health Inc., Cefla SC, Dentsply Sirona Inc., FUJIFILM Corp., General Electric Co., Hologic Inc., Koninklijke Philips N.V., Olympus Corp., PerkinElmer Inc, Planmeca Oy, Siemens Healthineers AG, Terarecon Inc, Thermo Fisher Scientific Inc., and Toshiba Corp.. Also, the advanced x-ray visualization systems market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global advanced X-ray visualization systems market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global advanced x-ray visualization systems market 2018 - 2022 ($ million)
4.2 Product Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Product Segment 2018 - 2022 ($ million)
4.3 End-user Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Product
6.1 Market segments
Exhibit 30: Chart on Product - Market share 2023-2028 (%)
Exhibit 31: Data Table on Product - Market share 2023-2028 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 Advanced X-ray visualization systems 2D/3D - Market size and forecast 2023-2028
Exhibit 34: Chart on Advanced X-ray visualization systems 2D/3D - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Advanced X-ray visualization systems 2D/3D - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Advanced X-ray visualization systems 2D/3D - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Advanced X-ray visualization systems 2D/3D - Year-over-year growth 2023-2028 (%)
6.4 Advanced X-ray visualization systems 3D/4D - Market size and forecast 2023-2028
Exhibit 38: Chart on Advanced X-ray visualization systems 3D/4D - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Advanced X-ray visualization systems 3D/4D - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Advanced X-ray visualization systems 3D/4D - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Advanced X-ray visualization systems 3D/4D - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Product
Exhibit 42: Market opportunity by Product ($ million)
Exhibit 43: Data Table on Market opportunity by Product ($ million)
7 Market Segmentation by End-user
7.1 Market segments
Exhibit 44: Chart on End-user - Market share 2023-2028 (%)
Exhibit 45: Data Table on End-user - Market share 2023-2028 (%)
7.2 Comparison by End-user
Exhibit 46: Chart on Comparison by End-user
Exhibit 47: Data Table on Comparison by End-user
7.3 Cardiology - Market size and forecast 2023-2028
Exhibit 48: Chart on Cardiology - Market size and forecast 2023-2028 ($ million)
Exhibit 49: Data Table on Cardiology - Market size and forecast 2023-2028 ($ million)
Exhibit 50: Chart on Cardiology - Year-over-year growth 2023-2028 (%)
Exhibit 51: Data Table on Cardiology - Year-over-year growth 2023-2028 (%)
7.4 Oncology - Market size and forecast 2023-2028
Exhibit 52: Chart on Oncology - Market size and forecast 2023-2028 ($ million)
Exhibit 53: Data Table on Oncology - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Chart on Oncology - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Oncology - Year-over-year growth 2023-2028 (%)
7.5 Orthodontics - Market size and forecast 2023-2028
Exhibit 56: Chart on Orthodontics - Market size and forecast 2023-2028 ($ million)
Exhibit 57: Data Table on Orthodontics - Market size and forecast 2023-2028 ($ million)
Exhibit 58: Chart on Orthodontics - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Orthodontics - Year-over-year growth 2023-2028 (%)
7.6 Orthopedic and neurology - Market size and forecast 2023-2028
Exhibit 60: Chart on Orthopedic and neurology - Market size and forecast 2023-2028 ($ million)
Exhibit 61: Data Table on Orthopedic and neurology - Market size and forecast 2023-2028 ($ million)
Exhibit 62: Chart on Orthopedic and neurology - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Orthopedic and neurology - Year-over-year growth 2023-2028 (%)
7.7 Market opportunity by End-user
Exhibit 64: Market opportunity by End-user ($ million)
Exhibit 65: Data Table on Market opportunity by End-user ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 67: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 69: Chart on Geographic comparison
Exhibit 70: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 UK - Market size and forecast 2023-2028
Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.10 Japan - Market size and forecast 2023-2028
Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.11 Canada - Market size and forecast 2023-2028
Exhibit 103: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 104: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 105: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 107: Market opportunity By Geographical Landscape ($ million)
Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 109: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 111: Overview on factors of disruption
11.4 Industry risks
Exhibit 112: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 113: Vendors covered
12.2 Market positioning of vendors
Exhibit 114: Matrix on vendor position and classification
12.3 Agfa Gevaert NV
Exhibit 115: Agfa Gevaert NV - Overview
Exhibit 116: Agfa Gevaert NV - Business segments
Exhibit 117: Agfa Gevaert NV - Key offerings
Exhibit 118: Agfa Gevaert NV - Segment focus
12.4 Canon Medical Systems Corp.
Exhibit 119: Canon Medical Systems Corp. - Overview
Exhibit 120: Canon Medical Systems Corp. - Business segments
Exhibit 121: Canon Medical Systems Corp. - Key offerings
Exhibit 122: Canon Medical Systems Corp. - Segment focus
12.5 Carestream Health Inc.
Exhibit 123: Carestream Health Inc. - Overview
Exhibit 124: Carestream Health Inc. - Product / Service
Exhibit 125: Carestream Health Inc. - Key offerings
12.6 Cefla SC
Exhibit 126: Cefla SC - Overview
Exhibit 127: Cefla SC - Product / Service
Exhibit 128: Cefla SC - Key offerings
12.7 Dentsply Sirona Inc.
Exhibit 129: Dentsply Sirona Inc. - Overview
Exhibit 130: Dentsply Sirona Inc. - Business segments
Exhibit 131: Dentsply Sirona Inc. - Key news
Exhibit 132: Dentsply Sirona Inc. - Key offerings
Exhibit 133: Dentsply Sirona Inc. - Segment focus
12.8 FUJIFILM Corp.
Exhibit 134: FUJIFILM Corp. - Overview
Exhibit 135: FUJIFILM Corp. - Business segments
Exhibit 136: FUJIFILM Corp. - Key news
Exhibit 137: FUJIFILM Corp. - Key offerings
Exhibit 138: FUJIFILM Corp. - Segment focus
12.9 General Electric Co.
Exhibit 139: General Electric Co. - Overview
Exhibit 140: General Electric Co. - Business segments
Exhibit 141: General Electric Co. - Key news
Exhibit 142: General Electric Co. - Key offerings
Exhibit 143: General Electric Co. - Segment focus
12.10 Hologic Inc.
Exhibit 144: Hologic Inc. - Overview
Exhibit 145: Hologic Inc. - Business segments
Exhibit 146: Hologic Inc. - Key news
Exhibit 147: Hologic Inc. - Key offerings
Exhibit 148: Hologic Inc. - Segment focus
12.11 Koninklijke Philips N.V.
Exhibit 149: Koninklijke Philips N.V. - Overview
Exhibit 150: Koninklijke Philips N.V. - Business segments
Exhibit 151: Koninklijke Philips N.V. - Key news
Exhibit 152: Koninklijke Philips N.V. - Key offerings
Exhibit 153: Koninklijke Philips N.V. - Segment focus
12.12 PerkinElmer Inc
Exhibit 154: PerkinElmer Inc - Overview
Exhibit 155: PerkinElmer Inc - Business segments
Exhibit 156: PerkinElmer Inc - Key news
Exhibit 157: PerkinElmer Inc - Key offerings
Exhibit 158: PerkinElmer Inc - Segment focus
12.13 Planmeca Oy
Exhibit 159: Planmeca Oy - Overview
Exhibit 160: Planmeca Oy - Product / Service
Exhibit 161: Planmeca Oy - Key offerings
12.14 Siemens Healthineers AG
Exhibit 162: Siemens Healthineers AG - Overview
Exhibit 163: Siemens Healthineers AG - Business segments
Exhibit 164: Siemens Healthineers AG - Key news
Exhibit 165: Siemens Healthineers AG - Key offerings
Exhibit 166: Siemens Healthineers AG - Segment focus
12.15 Terarecon Inc
Exhibit 167: Terarecon Inc - Overview
Exhibit 168: Terarecon Inc - Product / Service
Exhibit 169: Terarecon Inc - Key offerings
12.16 Thermo Fisher Scientific Inc.
Exhibit 170: Thermo Fisher Scientific Inc. - Overview
Exhibit 171: Thermo Fisher Scientific Inc. - Business segments
Exhibit 172: Thermo Fisher Scientific Inc. - Key news
Exhibit 173: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 174: Thermo Fisher Scientific Inc. - Segment focus
12.17 Toshiba Corp.
Exhibit 175: Toshiba Corp. - Overview
Exhibit 176: Toshiba Corp. - Business segments
Exhibit 177: Toshiba Corp. - Key news
Exhibit 178: Toshiba Corp. - Key offerings
Exhibit 179: Toshiba Corp. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 180: Inclusions checklist
Exhibit 181: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 182: Currency conversion rates for US$
13.4 Research methodology
Exhibit 183: Research methodology
Exhibit 184: Validation techniques employed for market sizing
Exhibit 185: Information sources
13.5 List of abbreviations
Exhibit 186: List of abbreviations